143 related articles for article (PubMed ID: 35117518)
1. Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma.
Feng F; Huang C; Xiao M; Wang H; Gao Q; Chen Z; Xu X; Zhou J; Li F; Li Y; Zhang D; Chang Y; Jiang X
Transl Cancer Res; 2020 Mar; 9(3):1698-1710. PubMed ID: 35117518
[TBL] [Abstract][Full Text] [Related]
2. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.
Feng F; Cheng Q; Yang L; Zhang D; Ji S; Zhang Q; Lin Y; Li F; Xiong L; Liu C; Jiang X
Oncotarget; 2017 Jan; 8(3):5349-5360. PubMed ID: 28029662
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.
Liu ZY; Xu GL; Tao HH; Yang YQ; Fan YZ
Cancer Cell Int; 2017; 17():20. PubMed ID: 28194091
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
[TBL] [Abstract][Full Text] [Related]
5. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
García P; Bizama C; Rosa L; Espinoza JA; Weber H; Cerda-Infante J; Sánchez M; Montecinos VP; Lorenzo-Bermejo J; Boekstegers F; Dávila-López M; Alfaro F; Leiva-Acevedo C; Parra Z; Romero D; Kato S; Leal P; Lagos M; Roa JC
Biol Res; 2020 Apr; 53(1):13. PubMed ID: 32293552
[TBL] [Abstract][Full Text] [Related]
6. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Yuan B; Zhao X; Wang X; Liu E; Liu C; Zong Y; Jiang Y; Hou M; Chen Y; Chen L; Zhang Y; Wang H; Fu J
Clin Transl Med; 2022 Jan; 12(1):e678. PubMed ID: 35075805
[TBL] [Abstract][Full Text] [Related]
8. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
9. Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer
Andus I; Prall F; Linnebacher M; Linnebacher CS
Front Oncol; 2023; 13():1089681. PubMed ID: 37228492
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer.
Yang D; Chen T; Zhan M; Xu S; Yin X; Liu Q; Chen W; Zhang Y; Liu D; Yan J; Huang Q; Wang J
Mol Ther Oncolytics; 2021 Mar; 20():59-70. PubMed ID: 33575471
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma.
Zhou F; Zhang Y; Sun J; Yang X
Cancer Cell Int; 2019; 19():190. PubMed ID: 31367188
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of serial subpopulations with highly metastatic potential via different metastatic routes].
He XW; Cao HQ; Xu LP; Zhou J; Xu L; Zhong ZX; Lu SC; Wu WX; Liu YB
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1852-5. PubMed ID: 22093790
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential].
Liu YB; He XW; Wang JW; Li JT; Li KQ; Liu FB; Xue JF; Zhu JH; Li B; Peng SY
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2117-21. PubMed ID: 17064616
[TBL] [Abstract][Full Text] [Related]
14. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
[TBL] [Abstract][Full Text] [Related]
15. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived cell models as preclinical tools for genome-directed targeted therapy.
Lee JY; Kim SY; Park C; Kim NK; Jang J; Park K; Yi JH; Hong M; Ahn T; Rath O; Schueler J; Kim ST; Do IG; Lee S; Park SH; Ji YI; Kim D; Park JO; Park YS; Kang WK; Kim KM; Park WY; Lim HY; Lee J
Oncotarget; 2015 Sep; 6(28):25619-30. PubMed ID: 26296973
[TBL] [Abstract][Full Text] [Related]
17. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway.
Wencong M; Jinghan W; Yong Y; Jianyang A; Bin L; Qingbao C; Chen L; Xiaoqing J
Front Oncol; 2020; 10():545. PubMed ID: 32363163
[TBL] [Abstract][Full Text] [Related]
18. Vimentin significantly promoted gallbladder carcinoma metastasis.
Dong P; He XW; Gu J; Wu WG; Li ML; Yang JH; Zhang L; Ding QC; Lu JH; Mu JS; Chen L; Li SG; Ding LF; Wang JW; Liu YB
Chin Med J (Engl); 2011 Dec; 124(24):4236-44. PubMed ID: 22340393
[TBL] [Abstract][Full Text] [Related]
19. Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.
Yang P; Javle M; Pang F; Zhao W; Abdel-Wahab R; Chen X; Meric-Bernstam F; Chen H; Borad MJ; Liu Y; Zou C; Mu S; Xing Y; Wang K; Peng C; Che X
Hepatobiliary Surg Nutr; 2019 Dec; 8(6):604-614. PubMed ID: 31929987
[TBL] [Abstract][Full Text] [Related]
20. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
